Another level at which this resistance is mediated is by transcription factors such as MITF (microphthalmia-associated transcription factor), which play a critical role in the differentiation of melanocytes and offer a unique resistance mechanism against BRAF and MEK inhibitors in malignant melanoma. The gene discussed is BRAF; the disease is melanoma.